Managing Risk in Nuclear Medicine

Approved For SNMMI-TS Voice Credit

Overview: This course provides the information necessary in making informed decisions in the management of radiopharmaceuticals for patient imaging and treatment. The material addresses five key objectives: Regulation of radiopharmaceuticals as prescription drugs; The term "compounding" as it pertains to radiopharmaceuticals; Terms and acronyms used by the FDA to designate approved radiopharmaceuticals; Aspects of institutional management of radiopharmaceuticals as prescription drugs; and Risks and liabilities associated with the handling of radiopharmaceuticals.

Note: If you need the registration code for this course, contact your Jubilant Radiopharma Radiopharmacies Division representative or email

SNMMI-TS VOICE Reference Number: CEC02832
Approved for 1.0 CEH(s) Category A  [California Scope: R]